Literature DB >> 35879887

Capturing the pool dilution effect in group testing regression: A Bayesian approach.

Stella Self1, Christopher McMahan2, Stefani Mokalled2.   

Abstract

Group (pooled) testing is becoming a popular strategy for screening large populations for infectious diseases. This popularity is owed to the cost savings that can be realized through implementing group testing methods. These methods involve physically combining biomaterial (eg, saliva, blood, urine) collected on individuals into pooled specimens which are tested for an infection of interest. Through testing these pooled specimens, group testing methods reduce the cost of diagnosing all individuals under study by reducing the number of tests performed. Even though group testing offers substantial cost reductions, some practitioners are hesitant to adopt group testing methods due to the so-called dilution effect. The dilution effect describes the phenomenon in which biomaterial from negative individuals dilute the contributions from positive individuals to such a degree that a pool is incorrectly classified. Ignoring the dilution effect can reduce classification accuracy and lead to bias in parameter estimates and inaccurate inference. To circumvent these issues, we propose a Bayesian regression methodology which directly acknowledges the dilution effect while accommodating data that arises from any group testing protocol. As a part of our estimation strategy, we are able to identify pool specific optimal classification thresholds which are aimed at maximizing the classification accuracy of the group testing protocol being implemented. These two features working in concert effectively alleviate the primary concerns raised by practitioners regarding group testing. The performance of our methodology is illustrated via an extensive simulation study and by being applied to Hepatitis B data collected on Irish prisoners.
© 2022 The Authors. Statistics in Medicine published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Bayesian models; biomarkers; dilution effect; group testing regression; measurement error

Mesh:

Substances:

Year:  2022        PMID: 35879887      PMCID: PMC9489666          DOI: 10.1002/sim.9532

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.497


  24 in total

1.  Regression analysis of group testing samples.

Authors:  M Xie
Journal:  Stat Med       Date:  2001-07-15       Impact factor: 2.373

2.  Robustness of group testing in the estimation of proportions.

Authors:  M Hung; W H Swallow
Journal:  Biometrics       Date:  1999-03       Impact factor: 2.571

3.  Informative prior distributions for ELISA analyses.

Authors:  Katy Klauenberg; Monika Walzel; Bernd Ebert; Clemens Elster
Journal:  Biostatistics       Date:  2015-01-09       Impact factor: 5.899

4.  Group testing case identification with biomarker information.

Authors:  Dewei Wang; Christopher S McMahan; Joshua M Tebbs; Christopher R Bilder
Journal:  Comput Stat Data Anal       Date:  2018-02-01       Impact factor: 1.681

5.  Group testing regression models with dilution submodels.

Authors:  Md S Warasi; Christopher S McMahan; Joshua M Tebbs; Christopher R Bilder
Journal:  Stat Med       Date:  2017-08-30       Impact factor: 2.373

6.  A pooled testing strategy for identifying SARS-CoV-2 at low prevalence.

Authors:  Leon Mutesa; Pacifique Ndishimye; Yvan Butera; Jacob Souopgui; Annette Uwineza; Robert Rutayisire; Ella Larissa Ndoricimpaye; Emile Musoni; Nadine Rujeni; Thierry Nyatanyi; Edouard Ntagwabira; Muhammed Semakula; Clarisse Musanabaganwa; Daniel Nyamwasa; Maurice Ndashimye; Eva Ujeneza; Ivan Emile Mwikarago; Claude Mambo Muvunyi; Jean Baptiste Mazarati; Sabin Nsanzimana; Neil Turok; Wilfred Ndifon
Journal:  Nature       Date:  2020-10-21       Impact factor: 49.962

7.  Pooled nucleic acid testing increases the diagnostic yield of acute HIV infections in a high-risk population compared to 3rd and 4th generation HIV enzyme immunoassays.

Authors:  Mel Krajden; Darrel Cook; Annie Mak; Ken Chu; Navdeep Chahil; Malcolm Steinberg; Michael Rekart; Mark Gilbert
Journal:  J Clin Virol       Date:  2014-07-03       Impact factor: 3.168

Review 8.  Pooling in high-throughput drug screening.

Authors:  Raghunandan M Kainkaryam; Peter J Woolf
Journal:  Curr Opin Drug Discov Devel       Date:  2009-05

9.  Investigational Testing for Zika Virus among U.S. Blood Donors.

Authors:  Paula Saá; Melanie Proctor; Gregory Foster; David Krysztof; Colleen Winton; Jeffrey M Linnen; Kui Gao; Jaye P Brodsky; Ronald J Limberger; Roger Y Dodd; Susan L Stramer
Journal:  N Engl J Med       Date:  2018-05-10       Impact factor: 91.245

10.  Determining an optimal pool size for testing beef herds for Johne's disease in Australia.

Authors:  Anna Ly; Navneet K Dhand; Evan S G Sergeant; Ian Marsh; Karren M Plain
Journal:  PLoS One       Date:  2019-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.